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January 2013290 Abstractsrent critical limb ischemia, loss of secondary patency, and major amputation
in those with primary occlusion were 55%, 79%, and 22%, respectively,
compared with 18%, 10%, and 10% for the remaining cohort (P .001). On
univariate analysis (hazard ratio [HR] [95% confidence interval]), African
American race (1.4 [1.01-1.9]), use of anticoagulants (1.54 [1.2-2]), use of
alternative/spliced vein conduit (1.44 [1.1-1.97]) and graft diameter 3
mm (1.97 [1.2-3.3]) were associated with increased risk of primary occlu-
sion. Onmultivariate analysis (HR [95% confidence interval]) graft diameter
3 mm (1.8 [1.1-3]) and use of anticoagulants (1.4 [1.04-1.89]) were
independent predictors. In 110 individuals, DUS had revealed no critical
threshold abnormalities prior to the thrombosis. On multivariate analysis,
graft diameter3mm (2.3 [1.2-4.7]) was the sole independent predictor of
these unheralded occlusions.
Conclusions: Approximately one-third of primary vein graft events are
occlusions even in the setting of DUS surveillance. Smaller diameter grafts
are at increased risk. These findings suggest that prevention of vein graft
thrombosis requires further improvements in risk stratification, surveillance,
and antithrombotic therapies.
Outcomes of Percutaneous Lower Extremity Procedures DependMore
on Indication Than Physician Specialty
Justin R. Wallace, MD, Theodore H. Yuo, MD, Rabih A. Chaer, MD,
Michel S. Makaroun, MD. UPMC, Pittsburgh, Pa
Objectives: Outcomes of percutaneous lower extremity procedures
(PLEP) have been recently linked to physician specialty. Unfortunately, the
indication for intervention was not reported. We sought to compare out-
comes between specialties performing PLEP for different indications in a
recent statewide inpatient discharge data set.
Methods: The Florida hospital discharge data from 2005 to 2009 was
reviewed for patients with PLEP during hospitalization. We assigned physi-
cian specialty as interventional radiology (IR), interventional cardiology
(IC), or vascular surgery (VS) based on physician-associated procedures.
Clinical indication was claudication or critical limb ischemia (CLI). We
limited our analysis to patients without concomitant open surgery during
hospitalization. We compared mortality, length of stay (LOS), major use of
intensive care unit (ICU), discharge disposition, and total charges between
specialties with logistic regression models, both unadjusted and adjusted for
demographic and clinical characteristics.
Results: A total of 15,398 patients (47% with CLI) had a PLEP. IC
performed the majority of procedures on claudicant patients (VS 30%, IC
57%, IR 13%), and VS performed themajority of procedures on CLI patients
(VS 50%, IC 22%, IR 27%). VS and IR were more likely than IC to treat CLI
patients (VS 59%, IR 65%, IC 26%; P  .001). Among CLI patients, there
was no difference in mortality rates between the three specialties in unad-
justed analysis (VS 2.3%, IR 3.0%, IC 2.1%, P .124), nor after adjustment
(odds ratio [OR] VS, reference; IR, 1.05; IC, 0.82; P  NS for both).
However, compared with VS, IR-treated patients were less likely to be
discharged home (OR, 0.73; P .001), LOS was longer (, 1.15 days; P
.001), major ICU use was more common (OR, 1.48; P  .001), and total
charges were higher (, $3267; P  .001). CLI was most predictive for
death (OR, 4.02; P .001), major ICUuse (OR, 1.95; P .001), discharge
home (OR, 0.50; P  .001), increased LOS (, 3.25 days; P  .001), and
total charges (, $18,364; P  .001).
Conclusions: VS treat the majority of CLI patients, while IC treat
mostly claudicant patients. Although physician specialty does impact several
clinical outcomes, the clinical indication for PLEP is the strongest predictor
of adverse outcomes. Future outcome analyses of PLEP should adjust for
clinical indication.
The Growing Burden of Restenosis in Peripheral Arterial Disease and
Its Impact on Outcomes
Douglas W. Jones, MD,1 Andres Schanzer, MD,2 Yuanyuan Zhao, MS,3
Michael S. Conte, MD,4 Philip P. Goodney, MD, MS3. 1New York
Presbyterian Hospital–Weill-Cornell Medical Center, New York, NY; 2Uni-
versity of Massachusetts Medical School, Worcester, Mass; 3Dartmouth
Hitchcock Medical Center, Lebanon, NH; 4University of California, San
Francisco, San Francisco, Calif
Objectives: Primary peripheral vascular interventions (PVI) and surgi-
cal bypass often suffer from restenosis, and secondary procedures performed
following restenosis may have poorer outcomes. We investigated how com-
monly lower extremity bypass (LEB) is performed in the setting of a prior
PVI or surgical bypass (“secondary LEB”), and how the outcomes of
secondary LEB compare to primary LEB.
Methods: Within the Vascular Surgery Group of New England
(VSGNE), we studied 3,504 patients who underwent LEB (2003-2011).
We compared utilization, indications, and outcomes between patients who
had primary versus secondary LEB. In-hospital outcomes and outcomes at
1-year follow-up were analyzed and inverse propensity weighting was per-
formed to adjust for differences between the two groups. Subgroup analyses
were performed to determine the influence of indication (claudication/
i
1ritical limb ischemia [CLI]) and prior intervention type (PVI/LEB/both)
n outcomes for secondary LEB.
Results: Overall, we studied 2350 patients undergoing primary LEB,
nd 1154 secondary LEB patients who underwent LEB in the setting of a
rior PVI (48%), a prior bypass (37%), or both (14%). Of all patients who
nderwent LEB, the proportion of patients undergoing secondary LEB has
oubled over the last 9 years (22% in 2003, 38% in 2011; P  .001). This
ncrease was evident in treatment of patients with CLI (18% to 28% of all
EB; P .001) and claudication (4% to 10% of all LEB; P .001) (Fig). In
rude analyses, rates of in-hospital myocardial infarction (4%), death (2%), or
mputation (0.5%) were similar between patients undergoing primary and
econdary LEB. However, secondary LEB patients had significantly worse
verall freedom from death, reintervention or above-ankle amputation
RAO; 58.9% vs 64.1%; P .001), and worse freedom from death or major
dverse limb event (MALE; 61.6% vs 67.5%; P 0.001) at 1-year follow-up.
hese results persisted, even when using inverse propensity weighting to
ccount for differences in patients characteristics. On subgroup analysis,
nferior RAO-free survival and MALE-free survival in patients undergoing
econdary LEB was independent of the type of prior revascularization (PVI,
EB, or both).
Conclusions: The proportion of patients who undergo LEB as a
econdary procedure has increased significantly in recent years in patients
ith both claudication and CLI and their associated outcomes are worse. In
n era where many advocate an endovascular-first approach to all patients
ith lower extremity PAD, physicians should consider the first intervention
arefully, not only because of the potential immediate implications, but also
ecause of the implications of treatment failure on future events.
ospital Reimbursement for Carotid Stenting and Carotid
ndarterectomy
elissa J. Donovan, MD, Daniel E. Ramirez, MD, Gregory D. Crenshaw,
D, Taylor A. Smith, MD, Hernan A. Bazan, MD, W. Charles Sternbergh,
II, MD. Ochsner Medical Center, New Orleans, La
Objectives: We previously demonstrated that carotid artery stenting
CAS) had a 40% greater cost than carotid endarterectomy (CEA) and did
ot provide superior outcome or a reduction in length of stay. However,
edicare hospital reimbursement for CAS (DRGs 34, 35, 36) is 12% to 61%
reater than that for CEA (DRGs 37, 38, 39). Hospital reimbursement for
hese procedures has not been previously examined.
Methods: A retrospective review of the hospital reimbursement and
ost for CAS and CEA was performed over a 33-month period at a tertiary
are institution. This financial data was calculated through the institution’s
clipsys cost accounting system, which captures hospital reimbursement as
ell as direct, variable, and fixed costs. Physician professional fees and
eimbursements were excluded. Data are presented as mean  standard
eviation.
Results: A total of 306 patients underwent CAS (n  132) or CEA
n 174). Hospital reimbursement was 18% higher for CAS ($12,000
5634) vs CEA ($10,160  $4687; P  .01). However, because of the
ignificantly higher materials’ costs of CAS, the net revenue (income) for
he hospital was 33% greater in patients undergoing CEA ($3426) than
AS ($2574) These differences in hospital reimbursement and net
Fig.ncome were consistent in asymptomatic (n  183), symptomatic (n 
23), and urgent (n  36) subgroups (see Fig). Asymptomatic patients
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Volume 57, Number 1 Abstracts 291generated a higher net revenue than symptomatic patients, whether
undergoing CEA or CAS.
Conclusions: Hospital reimbursement for CAS was 18% higher than
that for CEA. However, CEA was associated with a 33% higher net income
because of the 40% cost premium of CAS. Asymptomatic patients have the
lowest cost and highest net income of all the subgroups, likely due to less
complex clinical presentation and associated testing. At present, CAS is not
routinely cost-effective in a fee-for-service or capitated health care environ-
ment.
Surgical and Medical Management of Extracranial Carotid Artery
Aneurysms
Grant T. Fankhauser,MD,1WilliamM. Stone,MD,1 Richard J. Fowl,MD,1
Mark E. O’Donnell, MD,1 Thomas C. Bower, MD,2 Fredric B. Meyer,
MD,2 Samuel R. Money, MD1. 1Mayo Clinic Arizona, Phoenix, Ariz;
2Mayo Clinic, Rochester, Minn
Objectives: Extracranial carotid artery aneurysms (ECCA) are ex-
tremely rare, with limited information regarding management options.
Our purpose was to review our institution’s experience with ECCA over
15 years.
Methods: A retrospective review of patients diagnosed with ECCA
from 1998 to 2012 was performed. Symptoms, risk factors, etiology, diag-
nostic methods, treatments, and outcomes were reviewed.
Results: A total of 141 aneurysms were diagnosed in 132 patients
(69 men; mean age, 61 years). There were 116 (82%) pseudoaneurysms
and 25 (18%) true aneurysms: 114 (81%) aneurysms involved the internal
carotid, 11 common (8%), 15 the bifurcation (10%), and one external
(1%). A total of 69 aneurysms (49%) were asymptomatic and 72 (51%)
had symptoms (28 painless mass, 10 TIAs, 10 vision symptoms, 9
ruptures, 8 strokes, 4 painful mass, 1 dysphagia, 1 tongue weakness, 1
bruit). Diagnosis was by MR in 61 (43%), CT in 40 (28%), ultrasound in
29 (21%), angiography in nine (6.5%), and after rupture in two (1.5%).
Etiologies for true aneurysms included fibromuscular dysplasia in 15
patients, Ehlers Danlos in three, Marfan in one, and uncharacterized
connective tissue diseases in two. A total of 11 of 25 true aneurysms
(44%) were symptomatic, 15 (60%) true aneurysms underwent open
surgical treatment, and 10 (40%) were managed nonoperatively. Surgical
procedures included 14 (93%) aneurysmectomies with reconstruction (7
end-to-end, 4 saphenous interposition, 3 prosthetic interposition) and
one (7%) aneurysmorrhaphy. Postoperative complications included one
stroke during a mean follow-up of 31 months (range, 0-166 months). No
aneurysms managed nonoperatively required intervention during a mean
follow-up of 77 months (range, 1-115 months). Sixty of 116 pseudoan-
eurysms (52%) were symptomatic. Thirty-three pseudoaneurysms (29%)
underwent open surgery, 18 (15%) underwent endovascular interven-
tion, and 65 (56%) were managed medically. Pseudoaneurysm after
endarterectomy (28 patients, 24%) presented at a mean of 82 months
from the surgical procedure. Mean follow-up for all aneurysms was 33.9
months. One (0.7%) aneurysm-related death occurred (rupture treated
palliatively). No patient undergoing nonoperative management died or
suffered major morbidity related to the aneurysm. Nonoperative man-
agement was more common in asymptomatic patients (71%) than in
symptomatic patients (31%).
Conclusions: ECCA are uncommon and may present with varying
symptoms. All segments of the carotid artery are susceptible, although the
Fig.internal is most commonly affected. Open surgical intervention was more
common in patients with symptoms and with true aneurysms. Patients with iseudoaneurysms were more likely to undergo endovascular intervention.
onoperative treatment is safe in selected patients.
utcomes After Carotid Artery Surgery: Does Race Make a Difference?
uhammad Asad Khan, MD, Kuldeep Singh, MD, Jonathan Schor, MD,
onathan Deitch, MD. Staten Island University Hospital, Staten Island, NY
Objectives: Carotid occlusive disease is a major cause of stroke, ac-
ounting for 20% to 25% of cases in the USA. Several studies have described
higher incidence of stroke and attributed mortality in minority ethnic
roups. This study used a national database to identify ethnic disparity in
erms of risk profile, clinical presentation, and outcome in patients under-
oing carotid endarterectomy.
Methods: Using National Surgical Quality Improvement Program
NSQIP) data file from years 2005 to 2007, we identified patients under-
oing carotid endarterectomy, CPT code (35301). Patients were divided
nto two groups based on ethnicity into white and nonwhite. Patient
emographic, comorbidities, clinical presentation, postoperative morbidity,
nd mortality were compared between groups using 2 and t test as appro-
riate.
Results: Among 21,993 patients included in the study, 19,202
87.3%) were white and 2791 (12.7%) were nonwhite. The minority
onwhite group was more likely to present with symptomatic carotid
cclusive disease (7.5% vs 4.8%, P  .001), procedure was done emer-
ently (2.3% vs 1.4%, P  .001), was younger (69.8 vs 71.7 years, P 
001), and had a higher proportion of women (43.5% vs 40.9%, P 
010), The nonwhite group also had significantly higher cardiovascular
isk factors, including smoking, diabetes, coronary artery disease, history
f coronary revascularization, chronic obstructive pulmonary disease,
nd end-stage renal disease (Table). Although there was no difference in
ostoperative myocardial infarction, stroke, patients with nonwhite eth-
icity had higher overall postoperative morbidity (5.3% vs 4.0%, P 
001), mortality (1.2% vs 0.06, P  .001), and total hospital duration
3.3  6.9 vs 2.3  3.6 days, P  .001).
Conclusions: Review of the NSQIP database revealed ethnic minority
atients presented with advance carotid occlusive disease at time of carotid
urgery compared with white patients. This group also had higher postop-
rative morbidity and mortality and presented with higher number of
ardiovascular risk factors. The findings may be due to delay in seeking
reatment, limited access to care, and less rigorous screening. Further studies
re required to identify factors delaying care for carotid occlusive disease in
he nonwhite population.
able.
ariable White Nonwhite P
otal 19,202 (87.3%) 2791 (12.7%)
ymptomatic disease 925 (4.8%) 208 (7.5%) .001
mergency case 264 (1.4%) 64 (2.3%) .001
emale gender 7857 (86.6%) 1214 (13.4%) 0.01
ge, years 71.1  9.3 69.8  9.2 .001
ypertension 16,366 (85.2%) 2399 (86. %) .330
yocardial infarction 269 (1.4%) 45 (1.6%) .395
cute CHF in 30 days 150 (0.8%) 30 (1.1%) .111
OPD 2078 (10.8%) 202 (7.2%) .001
DDM 1651 (8.6%) 349 (12.5%) .001
IDDM 3411 (17.8%) 632 (22.6%) .001
moker 5296 (27.6%) 826 (29.6%) .028
CI 3635 (18.9%) 462 (2.1%) .003
ABG 4485 (23.4%) 561 (20.1%) .001
SRD 152 (0.8%) 53 (1.9%) .001
SA 3 2381 (12.4%) 380 (13.6%) .070
ostoperative variables
Stroke/CVA 296 (1.5%) 41 (1.5%) .861
Coma 24 hours 17 (0.1%) 6 (0.2%) .062
MI 120 (0.6%) 16 (0.6%) .885
SSI 42 (0.2%) 6 (0.2%) 1
Sepsis 85 (0.4%) 39 (1.4%) .001
Respiratory complications 316 (1.6%) 78 (2.8%) .001
Renal complication 37 (0.2%) 10 (0.4%) .081
Morbidity 765 (4.0%) 148 (5.3%) .001
Death 124 (0.6%) 34 (1.2%) .001
Length of surgery 114  44 119  46 .001
Duration of hospital stay 2.3  3.6 3.3  6.9 .001
SA, American Society of Anesthesiologists; CABG, coronary artery bypass
rafting; CHF, congestive heart failure; COPD, chronic obstructive pulmonary
isease; CVA, cerebrovascular accident; ESRD, end-stage renal disease; IDDM,
nsulin-dependent diabetes mellitus; MI, myocardial infarction; NIDDM, non–
nsulin-dependent diabetes mellitus; PCI, percutaneous coronary intervention.
